4841 - 4850 of 8673 Results
Title
Year
-
OPENTitle: Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 105Issue #:Start Page: 139End Page: 144Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.08.002Best OA location URL: http://www.prd-journal.com/article/S1353802022002553/pdfCitation Count: 10
-
RESTRICTEDTitle: Nutrition effects on brain outcomes and recovery in stroke after hospitalization (NOURISH): Randomized controlled trial protocol and rationaleJournal Name: Contemporary Clinical TrialsPublisher: Elsevier BVVol: 158Issue #:Start Page: 108108End Page: 108108Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cct.2025.108108Citation Count: 0
-
RESTRICTEDTitle: Dopaminergic dose adjustment and negative affective symptoms after deep brain stimulationJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 390Issue #:Start Page: 33End Page: 35Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2018.04.002Best OA location URL: https://zenodo.org/records/3873091/files/Main_text_JONS_revised_26_Mar_2018_CLEAN.pdfCitation Count: 2
-
OPENTitle: Disease-Specific Regions Outperform Whole-Brain Approaches in Identifying Progressive Supranuclear Palsy: A Multicentric MRI StudyJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2017.00100Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2017.00100/pdfCitation Count: 15
-
RESTRICTEDTitle: Parkinson's disease motor subtypes and bilateral GPi deep brain stimulation: One-year outcomesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 75Issue #:Start Page: 7End Page: 13Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.05.004Citation Count: 20
-
OPENTitle: Identification of small molecule dimethyoxyphenyl piperazine inhibitors of alpha-synuclein fibril growthJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-025-17658-yBest OA location URL: https://www.nature.com/articles/s41598-025-17658-y.pdfCitation Count: 0
-
OPENTitle: Altered sphingolipid function in Alzheimer's disease; a gene regulatory network approachJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 102Issue #:Start Page: 178End Page: 187Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.02.001Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2021.02.001Citation Count: 15
-
RESTRICTEDTitle: Functional ataxia in a specialized ataxia centerJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 120Issue #:Start Page: 106006End Page: 106006Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.106006Citation Count: 0
-
OPENTitle: Neuroimmunology of the Interleukins 13 and 4Journal Name: Brain SciencesPublisher: MDPI AGVol: 6Issue #: 2Start Page: 18End Page: 18Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci6020018Best OA location URL: https://www.mdpi.com/2076-3425/6/2/18/pdf?version=1465804812Citation Count: 102
-
OPENTitle: Six Action Steps to Address Global Disparities in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 9Start Page: 929End Page: 929Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1783Citation Count: 95